News

BioWorld1h
Edwards lands first CE mark for transfemoral mitral valve replacement
Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...
Orange County Business Journal6h
Edwards’ Sapien M3 Gains European Approval
The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement ...
Medical Device Network8h
Edwards secures CE mark for transfemoral mitral valve implant
Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...
MassDevice11h
Edwards wins CE mark for Sapien M3
Edwards Lifesciences (NYSE:EW) announced today that it received CE mark approval for its Sapien M3 mitral valve replacement ...
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...
Medscape3d
Rare Cor Triatriatum Case in Patient With HIV Uncovered
A rare case of cor triatriatum was diagnosed in a 34-year-old woman using transoesophageal echocardiography after initial ...
Medical Design & Outsourcing4d
How Cardiac Dimensions developed the Carillon Mitral Contour System — and makes the nitinol implant in-house
The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive mitral regurgitation therapy made possible by ...
Medscape5d
So Far, TAVI Device for Aortic Regurgitation Is Effective
A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...